Electra Therapeutics, Inc.

ETRA Nasdaq SEC CIK 2088082
Follow Electra Therapeutics Weekly email: filings, results

Financials

Reported figures only · latest: Q3 2026 USD · US GAAP
Net income −$23.9M −32.3% vs same quarter last year
EPS, diluted −$3.47
Operating income −$25.1M −47.2% vs same quarter last year
Net income by quarter
−$7.8M
−$17.6M
−$18.1M
−$22.2M
−$26.7M
−$23.9M
Q1 25 Q2 25 Q3 25 Q1 26 Q2 26 Q3 26

Source: SEC XBRL filings · latest filing